Intellia Therapeutics has taken another step toward its goal of winning the first approval for an in vivo CRISPR therapy, ...

Poseida Therapeutics’ gene therapy for hereditary angioedema (HAE) reduced kallikrein protein activity in a mouse model of ...

Meanwhile, Jeon Jong Seo settled in fourth place with a score of 4,789,661. Also read: Jelly Roll reveals dramatic 100-pound ...

Pharvaris mourns our distinguished colleague, Prof. Marcus Maurer, who passed away during the development and finalization of these posters. “The totality of data supporting deucrictibant’s potential ...

Additional real-world studies show sustained HAE attack rate reduction after initiating ORLADEYO, regardless of C1-INH status ...

Pharmaceuticals announced new real-world comparative research on the use of oral, once-daily ORLADEYO that found high rates of ...

Korean actor Jung Hae In talks about his love for India and Bollywood, his show getting remade in India and what love means to him ...

A single treatment with a CRISPR-Cas9 based gene editing therapy is enough to replace the daily medication of patients with ...

A single treatment with, a CRISPR-Cas9 based gene editing therapy, is enough to replace the daily medication of patients with hereditary angioedema (HAE), a condition characterized by severe, painful ...

Researchers expand on their phase one study demonstrating a single treatment with a CRISPR-Cas9-based gene editing therapy, ...

Highlights,Significant Increase in Holdings: Riverwater Partners LLC raised its stake in Haemonetics Co. by 185% in Q3 2024, ...